Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. (2020)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.2019003535
PubMed Identifier: 32187361
Publication URI: http://europepmc.org/abstract/MED/32187361
Type: Journal Article/Review
Volume: 135
Parent Publication: Blood
Issue: 20
ISSN: 0006-4971